Status:

COMPLETED

Metabolic Screening in Patients With Donnai-Barrow Syndrome

Lead Sponsor:

Massachusetts General Hospital

Conditions:

Donnai-Barrow Syndrome

Eligibility:

All Genders

Brief Summary

This study focuses on the genetics and metabolism of Donnai-Barrow Syndrome (DBS).

Detailed Description

The purpose of this study is to better understand the role of certain nutrients and vitamins in promoting the healthy development of individuals with Donnai-Barrow Syndrome. The investigators hope tha...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • All individuals affected with Donnai-Barrow Syndrome

Exclusion

    Key Trial Info

    Start Date :

    March 1 2010

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    June 30 2022

    Estimated Enrollment :

    78 Patients enrolled

    Trial Details

    Trial ID

    NCT01509287

    Start Date

    March 1 2010

    End Date

    June 30 2022

    Last Update

    November 22 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Massachusetts General Hospital

    Boston, Massachusetts, United States, 02114